Form D · Biotechnology
Neuro-Kinesis Corp
Inglewood, CA · CIK 0001814194
Offering snapshot reported Apr 24, 2026 · SEC filing
- Reported sold
- $51K Offering amount: $2M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2026 | Initial | $51,000 | No comparison | 5 | SEC filing |
| Jul 16, 2021 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Jun 11, 2020 | Initial | $50,000 | No comparison | 3 | SEC filing |
| Jun 11, 2020 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-581815
Source: Form D, filed Apr 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Adell | Director, Executive |
| Christopher Bissell | Executive |
| Dr. Thomas Chen, Md, Ph D | Director |
| Eli Gang | Director, Executive |
| Josh Shachar | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10524 S. La Cienega Blvd.
Inglewood, CA, 90304
Inglewood, CA, 90304